Litigation for DOXYCYCLINE

US Court Litigation for DOXYCYCLINE

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
10,058,564		1:18-cv-01588|D. Del.	2018-10-15	2020-07-21	35:271 Patent Infringement	District Court, D. Delaware	None
10,058,564		1:18-cv-01588|D. Del.	2018-10-15	2020-07-21	35:271 Patent Infringement	District Court, D. Delaware	None
10,058,564		1:19-cv-00440|D. Del.	2019-03-01	2020-08-31	35:271 Patent Infringement	District Court, D. Delaware	None
10,058,564		1:19-cv-00440|D. Del.	2019-02-28	2020-08-31	35:271 Patent Infringement	District Court, D. Delaware	None
7,211,267	Research Foundation of State University of New York v. Mylan Pharmaceuticals Inc.	1:09-cv-00184|D. Del.	2009-03-19	2012-05-25	35:271 Patent Infringement	District Court, D. Delaware	None
7,211,267		1:09-cv-00483|D. Del.	2009-07-02	2012-02-06	35:271 Patent Infringement	District Court, D. Delaware	Defendant
7,211,267		1:09-cv-00703|D. Del.	2009-09-18	2012-08-09	35:271 Patent Infringement	District Court, D. Delaware	None

Patent Trial and Appeal Board Cases for DOXYCYCLINE

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
8,206,740	Amneal Pharmaceuticals, LLC et al.		2013-06-20	06-20-2013	Supernus Pharmaceuticals, Inc.	Inter partes review		12-17-2013	Rong-Kun Chang
8,394,405	Amneal Pharamceuticals, LLC et al.		2013-06-20	06-20-2013	Supernus Pharmaceuticals, Inc.	Inter partes review		12-17-2013	Rong-Kun Chang
8,394,406	Amneal Pharamceuticals, LLC et al.		2013-06-20	06-20-2013	Supernus Pharmaceuticals, Inc.	Inter partes review		12-17-2013	Rong-Kun Chang
8,603,506	Dr. Reddy’s Laboratories, Ltd. et al.		2015-08-20	08-20-2015	GALDERMA LABORATORIES, INC.	Inter partes review		02-16-2016	Robert Ashley
8,603,506	Dr. Reddy’s Laboratories, Ltd. et al.		2015-08-20	08-20-2015	GALDERMA LABORATORIES, INC.	Inter partes review		02-16-2016	Robert Ashley
8,603,506	Dr. Reddy’s Laboratories, Ltd. et al.		2015-08-20	08-20-2015	GALDERMA LABORATORIES, INC.	Inter partes review		02-16-2016	Robert Ashley